Adial Pharmaceuticals, Inc. (ADIL)
NASDAQ: ADIL · IEX Real-Time Price · USD
1.86
+0.09 (5.08%)
At close: Dec 29, 2023, 4:00 PM
1.79
-0.07 (-3.76%)
After-hours: Dec 29, 2023, 7:57 PM EST
Adial Pharmaceuticals Market Cap
Adial Pharmaceuticals has a market cap or net worth of $2.27 million as of December 29, 2023. Its market cap has decreased by -65.15% in one year.
Market Cap
2.27M
Enterprise Value
1.95M
1-Year Change
-65.15%
Ranking
Category
Stock Price
$1.86
Market Cap Chart
Since July 30, 2018, Adial Pharmaceuticals's market cap has decreased from $26.30M to $2.27M, a decrease of -91.39%. That is a compound annual growth rate of -36.39%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Dec 29, 2023 | 2.30M | 4.55% |
Dec 28, 2023 | 2.20M | - |
Dec 27, 2023 | 2.20M | -8.33% |
Dec 26, 2023 | 2.40M | 9.09% |
Dec 22, 2023 | 2.20M | -4.35% |
Dec 21, 2023 | 2.30M | 9.52% |
Dec 20, 2023 | 2.10M | - |
Dec 19, 2023 | 2.10M | - |
Dec 18, 2023 | 2.10M | - |
Dec 15, 2023 | 2.10M | -4.55% |
Dec 14, 2023 | 2.20M | - |
Dec 13, 2023 | 2.20M | 4.76% |
Dec 12, 2023 | 2.10M | -8.70% |
Dec 11, 2023 | 2.30M | -8.00% |
Dec 8, 2023 | 2.50M | - |
Dec 7, 2023 | 2.50M | 4.17% |
Dec 6, 2023 | 2.40M | 4.35% |
Dec 5, 2023 | 2.30M | -8.00% |
Dec 4, 2023 | 2.50M | 8.70% |
Dec 1, 2023 | 2.30M | -14.81% |
Nov 30, 2023 | 2.70M | 3.85% |
Nov 29, 2023 | 2.60M | 4.00% |
Nov 28, 2023 | 2.50M | - |
Nov 27, 2023 | 2.50M | -3.85% |
Nov 24, 2023 | 2.60M | - |
View and export this data all the way back to 2018.
Start Free Trial.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Bone Biologics | 2.43M |
Neptune Wellness Solutions | 2.41M |
NanoVibronix | 2.35M |
NexImmune | 2.35M |
InVivo Therapeutics Holdings | 2.27M |
Cyclacel Pharmaceuticals | 2.25M |
SCWorx | 2.23M |
InMed Pharmaceuticals | 2.19M |